Senior Director, Clinical Field Monitoring and Trial Operations

Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets. Position Overview The Senior Director, Clinical Field Monitoring and Trial Operations (FMTO) provides strategic and operational leadership for Immunome’s clinical trial monitoring function, accountable for implementing Immunome’s contract field monitoring team and standardizing monitoring strategy, oversight activities, KPIs, and dashboards across all trials and monitoring vendors to ensure site-level data quality, patient safety, and protocol compliance across Immunome’s oncology portfolio. The Senior Director will lead and develop a high-performing field monitoring function, including a contract field monitoring team, partnering closely with Clinical Site and Trial Operations, Clinical Project Delivery Data Management, Clinical Development Systems, and Quality to ensure monitoring and TMF data, technology, and reporting enable enterprise-wide visibility into trial, site, and document performance. The Senior Director may also take on management and development of other trial operations staff or teams to support expansion of Immunome’s trial operations capabilities as well as leading various trial oversight activities and operational initiatives. Responsibilities Monitoring Strategy & Trial Oversight Own and evolve Immunome